The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors

A more common and noninvasive predicting biomarker for programmed cell death 1 (PD-1) antibody remains to be explored. We assessed 46 patients with advanced gastric cancer who received PD-1 antibody immunotherapy and 425-genes next-generation sequencing (NGS) testing. Patients who had a > 25% dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ying, Chen, Dong-Liang, Wang, Feng, Yang, Chao-pin, Chen, Xu-Xian, You, Jin-qi, Huang, Jin-Sheng, Shao, Yang, Zhu, Dong-Qin, Ouyang, Yu-Ming, Luo, Hui-Yan, Wang, Zhi-Qiang, Wang, Feng-Hua, Li, Yu-Hong, Xu, Rui-Hua, Zhang, Dong-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596978/
https://www.ncbi.nlm.nih.gov/pubmed/33126883
http://dx.doi.org/10.1186/s12943-020-01274-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596978/
https://www.ncbi.nlm.nih.gov/pubmed/33126883
http://dx.doi.org/10.1186/s12943-020-01274-7

Ejemplares similares